Humacyte, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $30.0M | $122.2M | $217.5M |
| FY2022 | $0 | $116.9M | $149.8M |
| FY2023 | $38.6M | $13.5M | $80.4M |
| FY2024 | $0 | $-52.7M | $44.9M |
| FY2025 | $35.4M | $3.1M | $50.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $30.0M | $122.2M | $217.5M |
| FY2022 | $0 | $116.9M | $149.8M |
| FY2023 | $38.6M | $13.5M | $80.4M |
| FY2024 | $0 | $-52.7M | $44.9M |
| FY2025 | $35.4M | $3.1M | $50.5M |